Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-017643
Filing Date
2024-06-20
Accepted
2024-06-20 16:27:33
Documents
1
Period of Report
2024-06-18

Document Format Files

Seq Description Document Type Size
1 form4-06202024_080629.html 4  
1 form4-06202024_080629.xml 4 5806
  Complete submission text file 0001415889-24-017643.txt   7449
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS, INC. (Issuer) CIK: 0001267813 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ABEONA THERAPEUTICS INC. 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019
Business Address
Silverstein Christine Berni (Reporting) CIK: 0001772546 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36576 | Film No.: 241056644